Skip to main content
. Author manuscript; available in PMC: 2014 May 5.
Published in final edited form as: Am J Obstet Gynecol. 2013 Apr;208(4):313.e1–313.e9. doi: 10.1016/j.ajog.2013.01.038

TABLE 5.

Maternal fatty acids

Group Visit Serum fatty acids n Mean SD Significance vs placeboa Significance vs visit 1b
EPA-rich fish oil 1 EPAc 42 0.29 0.18 NS
DHAc 42 4.24 2.30 NS
Total omega-3 highly unsaturated fatty acidsd 42 22.10 3.72 NS
3 EPAc 38 0.41 0.43 NS < .05
DHAc 38 4.38 2.42 NS NS
Total omega-3 highly unsaturated fatty acidsd 38 28.20 9.86 NS NS
DHA-rich fish oil 1 EPAc 41 0.31 0.24 NS
DHAc 41 4.66 2.29 NS
Total omega-3 highly unsaturated fatty acidsd 41 24.91 7.73 NS
3 EPAc 37 .38 .23 NS NS
DHAc 37 6.05 3.77 < .05 < .05
Total omega-3 highly unsaturated fatty acidsd 37 36.41 9.71 < .05
Placebo 1 EPAc 42 .34 .22
DHAc 42 3.85 1.77
Omega-3 highly unsaturated fatty acidsd 42 22.86 5.02
3 EPAc 41 0.36 0.40 NS
DHAc 41 3.70 1.62 NS
Omega-3 highly unsaturated fatty acidsd 41 27.46 9.55 NS

ANOVA, analysis of variance; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; NS, not significant; SD, standard deviation.

a

One-way ANOVA with Tukey’s multiple comparison test;

b

Student t test and signed rank test;

c

Expressed as percent of total fatty acids;

d

Expressed as percent of total highly unsaturated fatty acids.